Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Cell Mol Gastroenterol Hepatol ; 12(5): 1831-1845, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34358715

RESUMEN

BACKGROUND & AIMS: Aberrant immune activation is associated with numerous inflammatory and autoimmune diseases and contributes to cancer development and progression. Within the stomach, inflammation drives a well-established sequence from gastritis to metaplasia, eventually resulting in adenocarcinoma. Unfortunately, the processes that regulate gastric inflammation and prevent carcinogenesis remain unknown. Tristetraprolin (TTP) is an RNA-binding protein that promotes the turnover of numerous proinflammatory and oncogenic messenger RNAs. Here, we assess the role of TTP in regulating gastric inflammation and spasmolytic polypeptide-expressing metaplasia (SPEM) development. METHODS: We used a TTP-overexpressing model, the TTPΔadenylate-uridylate rich element mouse, to examine whether TTP can protect the stomach from adrenalectomy (ADX)-induced gastric inflammation and SPEM. RESULTS: We found that TTPΔadenylate-uridylate rich element mice were completely protected from ADX-induced gastric inflammation and SPEM. RNA sequencing 5 days after ADX showed that TTP overexpression suppressed the expression of genes associated with the innate immune response. Importantly, TTP overexpression did not protect from high-dose-tamoxifen-induced SPEM development, suggesting that protection in the ADX model is achieved primarily by suppressing inflammation. Finally, we show that protection from gastric inflammation was only partially due to the suppression of Tnf, a well-known TTP target. CONCLUSIONS: Our results show that TTP exerts broad anti-inflammatory effects in the stomach and suggest that therapies that increase TTP expression may be effective treatments of proneoplastic gastric inflammation. Transcript profiling: GSE164349.


Asunto(s)
Mucosa Gástrica/metabolismo , Mucosa Gástrica/patología , Inflamación/complicaciones , Metaplasia/etiología , Metaplasia/patología , Metaplasia/prevención & control , Tristetraprolina/genética , Animales , Biomarcadores , Modelos Animales de Enfermedad , Susceptibilidad a Enfermedades , Técnica del Anticuerpo Fluorescente , Regulación de la Expresión Génica , Inmunohistoquímica , Inflamación/etiología , Inflamación/metabolismo , Metaplasia/metabolismo , Ratones , Ratones Noqueados , Tamoxifeno/administración & dosificación , Tamoxifeno/efectos adversos
2.
Int J Cancer ; 134(1): 181-8, 2014 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-23797606

RESUMEN

A recent study showed an association between hookah/opium use and gastric cancer but no study has investigated the relationship with gastric precancerous lesions. We examined the association between hookah/opium and gastric precancerous lesions and subsequent gastric cancer. In a population-based cohort study, 928 randomly selected, healthy, Helicobacter pylori-infected subjects in Ardabil Province, Iran, were followed for 10 years. The association between baseline precancerous lesions and lifestyle risk factors (including hookah/opium) was analyzed using logistic regression and presented as odds ratios (ORs) and 95% confidence intervals (CIs). We also calculated hazard ratios (HRs) and 95% CIs for the associations of lifestyle risk factors and endoscopic and histological parameters with incident gastric cancers using Cox regression models. Additionally, the proportion of cancers attributable to modifiable risk factors was calculated. During 9,096 person-years of follow-up, 36 new cases of gastric cancer were observed (incidence rate: 3.96/1,000 persons-years). Opium consumption was strongly associated with baseline antral (OR: 3.2; 95% CI: 1.2-9.1) and body intestinal metaplasia (OR: 7.3; 95% CI: 2.5-21.5). Opium (HR: 3.2; 95% CI: 1.4-7.7), hookah (HR: 3.4; 95% CI: 1.7-7.1) and cigarette use (HR: 3.2; 95% CI: 1.4-7.5), as well as high salt intake, family history of gastric cancer, gastric ulcer and histological atrophic gastritis and intestinal metaplasia of body were associated with higher risk of gastric cancer. The fraction of cancers attributable jointly to high salt, low fruit intake, smoking (including hookah) and opium was 93% (95% CI: 83-98). Hookah and opium use are risk factors for gastric cancer as well as for precancerous lesions. Hookah, opium, cigarette and high salt intake are important modifiable risk factors in this high-incidence gastric cancer area.


Asunto(s)
Narcóticos/administración & dosificación , Opio/administración & dosificación , Lesiones Precancerosas/etiología , Fumar/efectos adversos , Neoplasias Gástricas/etiología , Adulto , Estudios de Cohortes , Femenino , Gastritis Atrófica/etiología , Infecciones por Helicobacter/complicaciones , Humanos , Incidencia , Masculino , Metaplasia/etiología , Factores de Riesgo
4.
Contemp Top Lab Anim Sci ; 40(2): 18-20, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11300682

RESUMEN

In a colony of 18 green anoles (Anolis carolinensis), 3 animals experienced focally thickened lips, ulcerative cheilitis, lethargy, depression, and weight loss over a 5-month period. In addition to crickets fed fresh fruit and leafy green vegetables, the diet of the green anoles consisted of a supply of mealworms that had been dusted with a commercial liquid vitamin supplement. The history, clinical findings, and histopathologic lesions were suggestive of hypovitaminosis A, which is known to cause squamous metaplasia of the mucus secreting glands and epithelial surfaces in many species.


Asunto(s)
Queilitis/veterinaria , Enfermedades de la Conjuntiva/veterinaria , Queratosis/veterinaria , Lagartos , Mucosa Bucal/patología , Deficiencia de Vitamina A/veterinaria , Animales , Enfermedades de la Conjuntiva/etiología , Enfermedades de la Conjuntiva/patología , Depresión/etiología , Queratosis/etiología , Queratosis/patología , Labio/patología , Metaplasia/etiología , Metaplasia/patología , Metaplasia/veterinaria , Fases del Sueño , Deficiencia de Vitamina A/etiología , Deficiencia de Vitamina A/patología , Pérdida de Peso
6.
Am Rev Respir Dis ; 147(2): 442-7, 1993 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8094278

RESUMEN

Experiments were performed to test whether recombinant secretory leukocyte proteinase inhibitor (rSLPI) was able to prevent the development of lipopolysaccharide (LPS)-mediated pulmonary emphysema, hemorrhage, and secretory cell metaplasia (SCM) in hamsters. Several groups of eight animals were intratracheally treated for four weeks, twice a week with 0.5 mg Escherichia coli LPS or with saline. In the first experiment, an additional group of eight hamsters was treated with 0.5 mg LPS mixed with 0.5 mg rSLPI, and the animals received another instillation of 0.5 mg rSLPI 7 h later. In the second experiment, 0.5 mg LPS, mixed with 1 mg rSLPI, was given while additional instillations of 1 mg rSLPI were performed 7 h and 31 h after the first dosage. In the third experiment, 0.5 mg LPS, mixed with 0.5, 1.5, or 3.0 mg rSLPI, was given while additional instillations of 0.5, 1.5, and 3.0 mg rSLPI, respectively, were performed 24 h and 48 h after the first dosage. Hamster lungs were examined for emphysema, hemorrhage, and SCM. In all three series of experiments, we observed a significant inhibition of LPS-mediated emphysema by rSLPI. This inhibition tended to be dose related. Inconclusive results were obtained on the inhibition of LPS-mediated hemorrhage. The development of LPS-mediated SCM was not affected by rSLPI. The LPS-mediated polymorphonuclear leukocyte (PMN) influx did not change when administrations of rSLPI were given additionally. We conclude that rSLPI is able to diminish significantly the development of LPS-mediated pulmonary emphysema in hamsters.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Proteínas , Enfisema Pulmonar/tratamiento farmacológico , Inhibidores de Serina Proteinasa/administración & dosificación , Animales , Anticuerpos/sangre , Especificidad de Anticuerpos , Cricetinae , Evaluación Preclínica de Medicamentos , Escherichia coli , Hemorragia/tratamiento farmacológico , Hemorragia/etiología , Hemorragia/inmunología , Instilación de Medicamentos , Lipopolisacáridos , Pulmón/patología , Enfermedades Pulmonares/tratamiento farmacológico , Enfermedades Pulmonares/etiología , Enfermedades Pulmonares/inmunología , Mesocricetus , Metaplasia/tratamiento farmacológico , Metaplasia/etiología , Metaplasia/inmunología , Proteínas Inhibidoras de Proteinasas Secretoras , Enfisema Pulmonar/etiología , Enfisema Pulmonar/inmunología , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/inmunología , Inhibidores de Serina Proteinasa/inmunología , Factores de Tiempo , Tráquea
7.
J Nutr ; 118(6): 675-80, 1988 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-3373332

RESUMEN

These studies were performed to follow a spectrum of relevant parameters in male Syrian golden hamsters fed either a vitamin A-deficient diet or the same diet supplemented with retinoic acid at 3 micrograms/g diet. Body weight and life span were not affected by the vitamin A-deficient diet until after 6-7 wk. Squamous metaplastic lesions of the Formalin-fixed tracheas were not generally observed in the hamsters fed the deficient diet until 6-7 wk, at which time blood retinol and liver retinyl palmitate levels had also decreased. Blood glucose levels remained normal (90 mg/dl) until about 7 wk but declined to about 40% of normal at 9 and 10 wk. Dietary retinoic acid supplementation of the vitamin-deficient diet (3 micrograms/g diet) inhibited the loss of retinol from blood and of retinyl palmitate from the liver so that these compounds were still present at 10 wk, but were not detectable in hamsters fed the vitamin A-deficient diet without retinoic acid.


Asunto(s)
Dieta , Hígado/metabolismo , Tretinoina/uso terapéutico , Deficiencia de Vitamina A/tratamiento farmacológico , Vitamina A/metabolismo , Animales , Glucemia/metabolismo , Cricetinae , Diterpenos , Epitelio/efectos de los fármacos , Epitelio/patología , Crecimiento/efectos de los fármacos , Esperanza de Vida , Hígado/efectos de los fármacos , Masculino , Mesocricetus , Metaplasia/etiología , Ésteres de Retinilo , Tráquea/efectos de los fármacos , Tráquea/patología , Vitamina A/análogos & derivados , Deficiencia de Vitamina A/metabolismo , Deficiencia de Vitamina A/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA